Security key
02043Q107
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)
CUSIP: 02043Q107
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 133,131,695
- Total 13F shares
- 118,559,398
- Share change
- -1,081,980
- Total reported value
- $22,525,153,339
- Put/Call ratio
- 128%
- Price per share
- $189.94
- Number of holders
- 469
- Value change
- -$212,624,410
- Number of buys
- 211
- Number of sells
- 204
Report period
Q2 2023
Institutions
469
Top holders
10
ALNY full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
ALNYLAM PHARMACEUTICALS, INC. SEC filings
ALNYLAM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
12%
|
16,476,201
|
$3,300,442,697 | — | 31 Mar 2023 | |
| FMR LLC |
13F
|
Company |
9.9%
|
13,170,835
|
$2,638,381,739 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.7%
|
11,608,167
|
$2,325,348,013 | — | 31 Mar 2023 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
6.5%
|
8,639,141
|
$1,730,592,725 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
6.4%
|
8,548,962
|
$1,712,528,068 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
4.6%
|
6,153,777
|
$1,232,724,610 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
3%
|
3,972,876
|
$795,848,000 | — | 31 Mar 2023 | |
| DODGE & COX |
13F
|
Company |
2.9%
|
3,894,535
|
$780,153,251 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2.3%
|
3,094,732
|
$619,936,002 | — | 31 Mar 2023 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
2.3%
|
3,030,821
|
$607,135,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
2,854,881
|
$571,884,879 | — | 31 Mar 2023 | |
| Capital Research Global Investors |
13F
|
Company |
1.8%
|
2,439,596
|
$488,679,651 | — | 31 Mar 2023 | |
| Capital International Investors |
13F
|
Company |
1.7%
|
2,229,589
|
$446,631,268 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,738,115
|
$347,683,983 | — | 31 Mar 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
1.3%
|
1,683,362
|
$337,211,076 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
1.1%
|
1,521,412
|
$304,769,252 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.92%
|
1,230,815
|
$246,557,144 | — | 31 Mar 2023 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
0.83%
|
1,105,000
|
$221,353,600 | — | 31 Mar 2023 | |
| Bellevue Group AG |
13F
|
Company |
0.66%
|
883,250
|
$176,932,640 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.58%
|
771,205
|
$154,487,787 | — | 31 Mar 2023 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.58%
|
765,772
|
$153,399,446 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.57%
|
761,584
|
$152,560,507 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.55%
|
731,022
|
$146,438,326 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.51%
|
673,878
|
$134,991,242 | — | 31 Mar 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
0.49%
|
658,226
|
$131,856,000 | — | 31 Mar 2023 | |
| Amundi |
13F
|
Individual |
0.49%
|
653,780
|
$131,292,100 | — | 31 Mar 2023 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
0.47%
|
621,208
|
$124,440,370 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.46%
|
609,106
|
$122,016,000 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.45%
|
604,075
|
$121,008,304 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.42%
|
554,337
|
$111,044,688 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.4%
|
535,959
|
$107,363,307 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.37%
|
488,300
|
$97,816,256 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.35%
|
459,566
|
$92,060,262 | — | 31 Mar 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.33%
|
444,608
|
$85,085,695 | — | 31 Mar 2023 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.32%
|
430,087
|
$86,154,993 | — | 31 Mar 2023 | |
| Mitsubishi UFJ Trust & Banking Corp |
13F
|
Company |
0.31%
|
407,934
|
$81,717,339 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.3%
|
405,363
|
$81,202,317 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.28%
|
367,375
|
$73,592,560 | — | 31 Mar 2023 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
359,864
|
$72,087,956 | — | 31 Mar 2023 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.26%
|
345,000
|
$69,110,400 | — | 31 Mar 2023 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.26%
|
340,967
|
$68,302,509 | — | 31 Mar 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.25%
|
337,528
|
$67,613,609 | — | 31 Mar 2023 | |
| Swedbank AB |
13F
|
Company |
0.25%
|
333,942
|
$66,895,260 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.25%
|
328,291
|
$60,530,400 | — | 31 Mar 2023 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.23%
|
311,918
|
$62,483,414 | — | 31 Mar 2023 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.22%
|
298,843
|
$59,864,399 | — | 31 Mar 2023 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.2%
|
272,882
|
$54,663,923 | — | 31 Mar 2023 | |
| Casdin Capital, LLC |
13F
|
Company |
0.2%
|
270,000
|
$54,086,400 | — | 31 Mar 2023 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.2%
|
263,448
|
$52,773,000 | — | 31 Mar 2023 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.19%
|
251,798
|
$50,440,176 | — | 31 Mar 2023 |
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q2 2023
As of 30 Jun 2023,
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) was held by
469 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
118,559,398 shares.
The largest 10 holders included
Capital World Investors, FMR LLC, VANGUARD GROUP INC, BAILLIE GIFFORD & CO, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Dodge & Cox, T. Rowe Price Investment Management, Inc., and JPMORGAN CHASE & CO.
This page lists
472
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
469
Q2 2023 holders
469
Holder diff
0
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.